Anti-Human CCL3L1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22067; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-Human CCL3L1 Polyclonal Antibody – your reliable ally in biotech research.
This highly specific antibody targets the human CCL3L1 protein, a chemokine that plays a crucial role in immune response and inflammation. CCL3L1 is known to attract and activate immune cells, making it a key player in various diseases and conditions.
The Anti-Human CCL3L1 Polyclonal Antibody is an essential tool for researchers studying the role of CCL3L1 in various biological processes. It can be used for Western blotting, immunohistochemistry, and ELISA, providing accurate and reliable results.
This antibody has been extensively tested and validated for its specificity and sensitivity in various experimental settings. It has been successfully used in research on autoimmune diseases, cancer, and infectious diseases, providing valuable insights into the role of CCL3L1 in these conditions.
Our Anti-Human CCL3L1 Polyclonal Antibody is the ideal choice for researchers looking to study the function of CCL3L1 in immune response, inflammation, and other biological processes. With its high specificity and sensitivity, it provides accurate and reliable results for a wide range of applications.
Our Anti-Human CCL3L1 Polyclonal Antibody is a powerful tool for researchers studying the role of CCL3L1 in immune response and inflammation. Its high specificity and sensitivity make it an essential component in various experimental techniques, including Western blotting, immunohistochemistry, and ELISA.
CCL3L1 is a chemokine that plays a crucial role in various diseases and conditions, making it an important target for research. Our antibody has been extensively tested and validated for its specificity and sensitivity, providing accurate and reliable results for studies on autoimmune diseases, cancer, and infectious diseases.
ProteoGenix catalogue number ARO-A22067. For research use only.
Target: C-C motif chemokine 3-like 1; G0/G1 switch regulatory protein 19-2; LD78-beta(1-70); PAT 464.2; Small-inducible cytokine A3-like 1; Tonsillar lymphocyte LD78 beta protein; LD78-beta(3-70); LD78-beta(5-70); CCL3L1; D17S1718; G0S19-2; SCYA3L1; CCL3L3; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
